Publications
Export 59 results:
Filters: Author is Chantal Mérette [Clear All Filters]
, “Symptom dimensions as alternative phenotypes to address genetic heterogeneity in schizophrenia and bipolar disorder.”, Eur J Hum Genet, vol. 20, no. 11, pp. 1182-8, 2012.
, “[Cognitive-behavioural therapy in early psychosis: an open study in a clinical setting].”, Can J Psychiatry, vol. 56, no. 1, pp. 51-61, 2011.
, “Global gene expression profiling of the polyamine system in suicide completers.”, Int J Neuropsychopharmacol, vol. 14, no. 5, pp. 595-605, 2011.
, “How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.”, Schizophr Bull, vol. 37, no. 4, pp. 811-21, 2011.
, “Latent class model with familial dependence to address heterogeneity in complex diseases: adapting the approach to family-based association studies.”, Genet Epidemiol, vol. 35, no. 3, pp. 182-9, 2011.
, “Prevalence of insomnia and its treatment in Canada.”, Can J Psychiatry, vol. 56, no. 9, pp. 540-8, 2011.
, “Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectories.”, Schizophr Bull, vol. 37, no. 6, pp. 1218-28, 2011.
, “Young offspring at genetic risk of adult psychoses: the form of the trajectory of IQ or memory may orient to the right dysfunction at the right time.”, PLoS One, vol. 6, no. 4, p. e19153, 2011.
, “Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study.”, Mol Psychiatry, vol. 15, no. 8, pp. 831-43, 2010.
, “Retinal response to light in young nonaffected offspring at high genetic risk of neuropsychiatric brain disorders.”, Biol Psychiatry, vol. 67, no. 3, pp. 270-4, 2010.
, “Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse.”, Schizophr Res, vol. 118, no. 1-3, pp. 285-91, 2010.
, “Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype.”, Eur J Hum Genet, vol. 17, no. 8, pp. 1034-42, 2009.
, “Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.”, JAMA, vol. 301, no. 19, pp. 2005-15, 2009.
, “Incidence and risk factors of insomnia in a population-based sample.”, Sleep, vol. 32, no. 8, pp. 1027-37, 2009.
, “The natural history of insomnia: a population-based 3-year longitudinal study.”, Arch Intern Med, vol. 169, no. 5, pp. 447-53, 2009.
, “A new strategy for linkage analysis under epistasis taking into account genetic heterogeneity.”, Hum Hered, vol. 68, no. 4, pp. 231-42, 2009.
, “Profiling brain expression of the spermidine/spermine N1-acetyltransferase 1 (SAT1) gene in suicide.”, Am J Med Genet B Neuropsychiatr Genet, vol. 150B, no. 7, pp. 934-43, 2009.
, “Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families.”, Schizophr Bull, vol. 35, no. 5, pp. 919-30, 2009.
, “Decomposing the autism phenotype into familial dimensions.”, Am J Med Genet B Neuropsychiatr Genet, vol. 147B, no. 1, pp. 3-9, 2008.
, “Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes.”, Schizophr Res, vol. 100, no. 1-3, pp. 281-90, 2008.
, “Replication of linkage with bipolar disorder on chromosome 16p in the Eastern Quebec population.”, Am J Med Genet B Neuropsychiatr Genet, vol. 147B, no. 6, pp. 737-44, 2008.
, “Using disease symptoms to improve detection of linkage under genetic heterogeneity.”, Genet Epidemiol, vol. 32, no. 5, pp. 476-86, 2008.
, “Family history of insomnia in a population-based sample.”, Sleep, vol. 30, no. 12, pp. 1739-45, 2007.
, “Informative phenotypes for genetic studies of psychiatric disorders.”, Am J Med Genet B Neuropsychiatr Genet, vol. 144B, no. 5, pp. 581-8, 2007.
, “Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine.”, Am J Med Genet B Neuropsychiatr Genet, vol. 144B, no. 8, pp. 1063-9, 2007.
